Publications | Lund University Publications

101 – 110 of 322

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=issn+exact+%221351-8216%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
10
11
12
13
…
33
next »

2014
Mark Laboratory aspects of von Willebrand disease : test repertoire and options for activity assays and genetic analysis
Castaman, G ; Hillarp, A ^LU and Goodeve, A (2014) In Haemophilia 20. p.65-70
- Contribution to journal › Scientific review
Mark Managing Haemophilia for Life: 4th Haemophilia Global Summit
Astermark, Jan ^LU ; Dolan, G. ; Hilberg, T. ; Jimenez-Yuste, V. ; Laffan, M. ; Lassila, R. ; Lobet, S. ; Martinoli, C. and Perno, C. -F. (2014) In Haemophilia 20. p.1-20
- Contribution to journal › Scientific review
Mark A comparison of the treatment of patients with factor IX deficiency to that of those with factor VIII deficiency: results of an International Survey conducted as part of the International FIX Treatment Network.
Berntorp, Erik ^LU ; Shapiro, A D ; Waters, J and Astermark, Jan ^LU (2014) In Haemophilia 20(5). p.362-364
- Contribution to journal › Letter
Mark Prospective observational cohort studies for studying rare diseases: the European PedNet Haemophilia Registry
Fischer, K. ; Ljung, Rolf ^LU ; Platokouki, H. ; Liesner, R. ; Claeyssens, S. ; Smink, E. and Van den Berg, H. M. (2014) In Haemophilia 20(4). p.280-286
- Contribution to journal › Article
Mark Switching clotting factor concentrates: considerations in estimating the risk of immunogenicity
Matino, D. ; Lillicrap, D. ; Astermark, Jan ^LU ; Dolan, G. ; Kessler, C. ; Lambert, T. ; Makris, M. ; O'Donnell, J. ; Pipe, S. and Santagostino, E. , et al. (2014) In Haemophilia 20(2). p.200-206
- Contribution to journal › Article
Mark Pharmacokinetics, phenotype and product choice in haemophilia B: how to strike a balance?
Berntorp, Erik ^LU ; Dolan, G ; Hermans, C ; Laffan, M ; Santagostino, E and Tiede, A (2014) In Haemophilia 20. p.1-11
- Contribution to journal › Article
Mark Similar bleeding phenotype in young children with haemophilia A or B : A cohort study
Clausen, Niels ; Petrini, P. ; Claeyssens-Donadel, S. ; Gouw, S. C. ; Liesner, R. ; Altisent, C. ; Auerswald, G. ; Carcao, M. ; Chalmers, E. and Chambost, H. , et al. (2014) In Haemophilia 20(6). p.747-755
- Contribution to journal › Article
2013
Mark Incidence, mortality rates and causes of deaths in haemophilia patients in Sweden.
Lövdahl, Susanna ^LU ; Henriksson, Marie ^LU ; Baghaei, F ; Holmström, Eva M ^LU ; Nilsson, J-Å ; Berntorp, Erik ^LU and Astermark, Jan ^LU (2013) In Haemophilia 19(3). p.362-369
- Contribution to journal › Article
Mark Pharmacokinetics of plasma-derived and recombinant factor IX: using population pharmacokinetics with sparse sampling data needs further study.
Berntorp, Erik ^LU (2013) In Haemophilia 19(6). p.805-807
- Contribution to journal › Debate/Note/Editorial
Mark Novel coagulation factor concentrates: Issues relating to their clinical implementation and pharmacokinetic assessment for optimal prophylaxis in haemophilia patients.
Ljung, Rolf ^LU ; Auerswald, G ; Benson, G ; Jetter, A ; Jiménez-Yuste, V ; Lambert, T ; Morfini, M ; Remor, E ; Sørensen, B and Salek, S Z (2013) In Haemophilia 19(4). p.481-486
- Contribution to journal › Scientific review

« previous
1
…
10
11
12
13
…
33
next »

your query:: Remove issn: 1351-8216